Drug recall · May 18, 2016
Ondansetron Tablets USP recall
Why: Failed Impurities/Degradation Specifications; 12 month stability time point
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30
- Lots / codes
Lot number C500691, exp 12/2016
- Quantity
- 50,280 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide
- Initiated
- March 30, 2016 · Voluntary: Firm initiated
- Classified
- May 9, 2016
- Reported
- May 18, 2016
- Ended
- April 10, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ondansetron
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.